Germany· DE-A57-3813f5ed66cf9a3e
Femoston Conti
A medicinal product containing dydrogesterone, estradiol, registered in Germany by Theramex Ireland Limited.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Dydrogesterone, Estradiol
- Manufacturer
- Theramex Ireland Limited
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dydrogesterone, estradiol in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEstradiol 1mg / Dydrogesterone 10mg tabletsExeltis UK Ltd
- NetherlandsFemoston 1/10, filmomhulde tablettenAbbott B.V.
- SwedenFemoston 1 mg + 1 mg/10 mg Filmdragerad tablettEbb Medical AB
- PolandFemoston contiTheramex Ireland Limited
- IrelandFemoston 1/10mg film-coated tabletsTheramex Ireland Limited
- NorwayFemostonViatris
- SwitzerlandFemoston
- SpainFEMFASCON 1 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULATheramex Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Femoston, Femoston Conti
- Belgium · Femoston, Femoston 2/10
- Cyprus · Femoston
- Czechia · Femoston, Femoston Conti
- Denmark · Femoston, Femoston Conti
- Estonia · Femoston, Femoston Conti
- Spain · Femfascon, Femoston
- Finland · Femoston, Femoston Conti
- France · Climaston
- Greece · Femaston
- Croatia · Femoston, Femoston Conti
- Ireland · Femoston, Femoston-Conti
- Italy · Femoston, Femoston Conti
- Lithuania · Femoston, Femoston Conti
- Luxembourg · Femoston, Femoston Conti
- Latvia · Femoston, Femoston Conti
- Malta · Femoston, Femoston-Conti
- Netherlands · Femoston, Femoston Continu
- Norway · Femoston, Femostonconti
- Poland · Femoston, Femoston Conti
- Portugal · Femoston
- Sweden · Femoston, Femostonconti
- Slovenia · Femphascon Conti
- Slovakia · Femoston, Femoston Conti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f678fcc8-cd93-442d-8eaf-aa634eb2652c GET /v1/drugs/f678fcc8-cd93-442d-8eaf-aa634eb2652c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Dydrogesterone, Estradiol",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about dydrogesterone, estradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.